Modeling and Simulation in Drug Development with SimBiology

Pfizer CEO Albert Bourla, speaking in the Oval Office on Tuesday about the company's deal to lower drug prices, said the winner of the deal will "clearly will be the American patient." Bourla said the company satisfied all four of the requests President Trump outlined. Among the other steps is pursuing tougher price negotiations abroad and adopting models that sell its medicines directly to consumers or businesses. As part of the deal, Pfizer has also agreed to a three-year grace period during w